GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.
Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y. · 2021
Read GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. by Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8419463.txt.
Description
Zhao and co-authors look past the pancreas to the wider effects of GLP-1 receptor agonists. These drugs are widely used for type 2 diabetes. They aid weight loss, guard insulin-making cells, and carry few side effects.
The GLP-1 receptor sits in many tissues beyond the pancreas. Its activation can calm nerve inflammation and support nerve growth. It can improve heart function, curb appetite, and slow stomach emptying. It also shapes blood fat handling and cuts fat storage. The review covers effects on the nervous, heart, and hormone systems. Links with metabolism and tumors get their own treatment. Prospects for wider use look strong.
Catalog record
| CREATOR | Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 108 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |